| Chudnoff, Scott |
NCT05394662: Safety and Effectiveness of Juveena™ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions |
|
|
| Recruiting | 3 | 150 | US | Juveena Hydrogel System | Rejoni Inc. | Intrauterine Adhesion | 03/25 | 03/25 | | |
NCT04267562: Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness |
|
|
| Completed | N/A | 219 | US | Minitouch System | MicroCube, LLC | Menorrhagia, Heavy Menstrual Bleeding, Heavy Uterine Bleeding | 07/22 | 12/23 | | |
NCT06572163: Clinical Validation Study of the Eximis CS (Contained Segmentation) System |
|
|
| Recruiting | N/A | 30 | US | Eximis CS (Contained Segmentation) System | Eximis Surgical, Proxima Clinical Research | Laparoscopic Gynecological Surgical Procedures | 01/25 | 04/25 | | |
| Silverberg, Kaylen |
NCT05394662: Safety and Effectiveness of Juveena™ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions |
|
|
| Recruiting | 3 | 150 | US | Juveena Hydrogel System | Rejoni Inc. | Intrauterine Adhesion | 03/25 | 03/25 | | |
NCT05811585: PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery |
|
|
| Completed | N/A | 153 | Europe, US | ADEPT | Baxter Healthcare Corporation | Adhesion | 05/24 | 05/24 | | |
| Sher, Olivia |
NCT05394662: Safety and Effectiveness of Juveena™ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions |
|
|
| Recruiting | 3 | 150 | US | Juveena Hydrogel System | Rejoni Inc. | Intrauterine Adhesion | 03/25 | 03/25 | | |
NCT06572163: Clinical Validation Study of the Eximis CS (Contained Segmentation) System |
|
|
| Recruiting | N/A | 30 | US | Eximis CS (Contained Segmentation) System | Eximis Surgical, Proxima Clinical Research | Laparoscopic Gynecological Surgical Procedures | 01/25 | 04/25 | | |
